188 related articles for article (PubMed ID: 24016853)
1. A silk fibroin based hepatocarcinoma model and the assessment of the drug response in hyaluronan-binding protein 1 overexpressed HepG2 cells.
Kundu B; Saha P; Datta K; Kundu SC
Biomaterials; 2013 Dec; 34(37):9462-74. PubMed ID: 24016853
[TBL] [Abstract][Full Text] [Related]
2. Increased hyaluronan levels in HABP1/p32/gC1qR overexpressing HepG2 cells inhibit autophagic vacuolation regulating tumor potency.
Saha P; Ghosh I; Datta K
PLoS One; 2014; 9(7):e103208. PubMed ID: 25061661
[TBL] [Abstract][Full Text] [Related]
3. Engineered silk fibroin protein 3D matrices for in vitro tumor model.
Talukdar S; Mandal M; Hutmacher DW; Russell PJ; Soekmadji C; Kundu SC
Biomaterials; 2011 Mar; 32(8):2149-59. PubMed ID: 21167597
[TBL] [Abstract][Full Text] [Related]
4. Osteogenic and adipogenic differentiation of rat bone marrow cells on non-mulberry and mulberry silk gland fibroin 3D scaffolds.
Mandal BB; Kundu SC
Biomaterials; 2009 Oct; 30(28):5019-30. PubMed ID: 19577292
[TBL] [Abstract][Full Text] [Related]
5. Functional hepatocyte clusters on bioactive blend silk matrices towards generating bioartificial liver constructs.
Janani G; Nandi SK; Mandal BB
Acta Biomater; 2018 Feb; 67():167-182. PubMed ID: 29223705
[TBL] [Abstract][Full Text] [Related]
6. Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering.
Garcia-Fuentes M; Meinel AJ; Hilbe M; Meinel L; Merkle HP
Biomaterials; 2009 Oct; 30(28):5068-76. PubMed ID: 19564040
[TBL] [Abstract][Full Text] [Related]
7. Chondrogenic differentiation of rat MSCs on porous scaffolds of silk fibroin/chitosan blends.
Bhardwaj N; Kundu SC
Biomaterials; 2012 Apr; 33(10):2848-57. PubMed ID: 22261099
[TBL] [Abstract][Full Text] [Related]
8. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells.
Subia B; Dey T; Sharma S; Kundu SC
ACS Appl Mater Interfaces; 2015 Feb; 7(4):2269-79. PubMed ID: 25557227
[TBL] [Abstract][Full Text] [Related]
9. Silk protein fibroin from Antheraea mylitta for cardiac tissue engineering.
Patra C; Talukdar S; Novoyatleva T; Velagala SR; Mühlfeld C; Kundu B; Kundu SC; Engel FB
Biomaterials; 2012 Mar; 33(9):2673-80. PubMed ID: 22240510
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G
Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477
[TBL] [Abstract][Full Text] [Related]
11. Non-bioengineered silk gland fibroin protein: characterization and evaluation of matrices for potential tissue engineering applications.
Mandal BB; Kundu SC
Biotechnol Bioeng; 2008 Aug; 100(6):1237-50. PubMed ID: 18383269
[TBL] [Abstract][Full Text] [Related]
12. Silk fibroin film from non-mulberry tropical tasar silkworms: A novel substrate for in vitro fibroblast culture.
Acharya C; Ghosh SK; Kundu SC
Acta Biomater; 2009 Jan; 5(1):429-37. PubMed ID: 18676188
[TBL] [Abstract][Full Text] [Related]
13. Effect of hyaluronan molecular weight on structure and biocompatibility of silk fibroin/hyaluronan scaffolds.
Fan Z; Zhang F; Liu T; Zuo BQ
Int J Biol Macromol; 2014 Apr; 65():516-23. PubMed ID: 24495557
[TBL] [Abstract][Full Text] [Related]
14. Non-mulberry silk gland fibroin protein 3-D scaffold for enhanced differentiation of human mesenchymal stem cells into osteocytes.
Mandal BB; Kundu SC
Acta Biomater; 2009 Sep; 5(7):2579-90. PubMed ID: 19345621
[TBL] [Abstract][Full Text] [Related]
15. Bio-inspired fabrication of fibroin cryogels from the muga silkworm Antheraea assamensis for liver tissue engineering.
Kundu B; Kundu SC
Biomed Mater; 2013 Oct; 8(5):055003. PubMed ID: 24002731
[TBL] [Abstract][Full Text] [Related]
16. The effects of pore architecture in silk fibroin scaffolds on the growth and differentiation of mesenchymal stem cells expressing BMP7.
Zhang Y; Fan W; Ma Z; Wu C; Fang W; Liu G; Xiao Y
Acta Biomater; 2010 Aug; 6(8):3021-8. PubMed ID: 20188872
[TBL] [Abstract][Full Text] [Related]
17. A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing.
Yip D; Cho CH
Biochem Biophys Res Commun; 2013 Apr; 433(3):327-32. PubMed ID: 23501105
[TBL] [Abstract][Full Text] [Related]
18. A novel platform for drug testing: Biomimetic three-dimensional hyaluronic acid-based scaffold seeded with human hepatocarcinoma cells.
Turtoi M; Anghelache M; Bucatariu SM; Deleanu M; Voicu G; Safciuc F; Manduteanu I; Fundueanu G; Simionescu M; Calin M
Int J Biol Macromol; 2021 Aug; 185():604-619. PubMed ID: 34216662
[TBL] [Abstract][Full Text] [Related]
19. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
Villa R; Cerroni B; Viganò L; Margheritelli S; Abolafio G; Oddo L; Paradossi G; Zaffaroni N
Colloids Surf B Biointerfaces; 2013 Oct; 110():434-42. PubMed ID: 23759384
[TBL] [Abstract][Full Text] [Related]
20. Spheroid formation and expression of liver-specific functions of human hepatocellular carcinoma-derived FLC-4 cells cultured in lactose-silk fibroin conjugate sponges.
Gotoh Y; Ishizuka Y; Matsuura T; Niimi S
Biomacromolecules; 2011 May; 12(5):1532-9. PubMed ID: 21449575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
